James C. Irvine

Affiliations: 
University of St Andrews, Saint Andrews, Scotland, United Kingdom 
Area:
carbohydrate chemistry
Website:
https://doi.org/10.1098/rsbm.1953.0011
Google:
"James Irvine"
Bio:

http://catalog.hathitrust.org/Record/007890777
http://en.wikipedia.org/wiki/James_Irvine_(chemist)

Mean distance: 9.02
 
SNBCP

Parents

Sign in to add mentor
Johannes Wislicenus grad student 1901 Leipzig University
 (Über einige Derivate des Orthomethoxybenzaldehydes)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Andrews KL, Sampson AK, Irvine JC, et al. (2016) Nitroxyl (HNO) reduces endothelial and monocyte activation and promotes M2 macrophage polarisation. Clinical Science (London, England : 1979)
Sampson AK, Irvine JC, Shihata WA, et al. (2015) Compound 21 prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo. British Journal of Pharmacology
Woollard KJ, Lumsden NG, Andrews KL, et al. (2014) Raised soluble P-selectin moderately accelerates atherosclerotic plaque progression. Plos One. 9: e97422
Irvine JC, Ravi RM, Kemp-Harper BK, et al. (2013) Nitroxyl donors retain their depressor effects in hypertension. American Journal of Physiology. Heart and Circulatory Physiology. 305: H939-45
Irvine JC, Cao N, Gossain S, et al. (2013) HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO. American Journal of Physiology. Heart and Circulatory Physiology. 305: H365-77
Irvine JC, Ganthavee V, Love JE, et al. (2012) The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy. Plos One. 7: e44481
Lin EQ, Irvine JC, Cao AH, et al. (2012) Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation. Plos One. 7: e34892
Irvine JC, Kemp-Harper BK, Widdop RE. (2011) Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA/NO. Antioxidants & Redox Signaling. 14: 1615-24
Bullen ML, Miller AA, Andrews KL, et al. (2011) Nitroxyl (HNO) as a vasoprotective signaling molecule. Antioxidants & Redox Signaling. 14: 1675-86
Irvine JC, Robertson GJ. (2010) The inter‐conversion of simple sugars Recueil Des Travaux Chimiques Des Pays-Bas. 57: 575-581
See more...